Source:http://linkedlifedata.com/resource/pubmed/id/11026647
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2001-2-20
|
pubmed:abstractText |
The human heart contains at least four distinct beta-adrenoceptor subtypes, three of which have been cloned. However, the binding properties of beta-blockers to the different beta-adrenoceptor subpopulations are not yet thoroughly characterized. Human beta1-, beta2- and beta3-adrenoceptors were expressed in COS-7 cells and [125I]iodocyanopindolol saturation binding, and competition experiments with commonly used beta-blockers were performed in the respective membrane preparations. Atenolol and metoprolol were about fivefold selective for beta1- versus beta2- and beta3-adrenoceptors. Bisoprolol was approximately 15-fold selective for beta1- versus beta2- and approximately 31-fold selective for beta1- versus beta3-adrenoceptors. Carvedilol was nonselective for any beta-adrenoceptor subtype. We conclude that the beta1-selectivities of atenolol, metoprolol, and bisoprolol are lower in COS cell membranes compared with previous investigations performed in native membranes. All beta-blockers investigated bind to beta3-adrenoceptors. Differential binding properties to beta3-adrenoceptors might imply different responses as to body weight, cardiac contractility, heart rate, and growth regulation. This might imply differential indications for the drugs investigated.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Complementary,
http://linkedlifedata.com/resource/pubmed/chemical/Iodocyanopindolol,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Adrenergic, beta-1,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Adrenergic, beta-2,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Adrenergic, beta-3
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0160-2446
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
466-71
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11026647-Adrenergic beta-Antagonists,
pubmed-meshheading:11026647-Animals,
pubmed-meshheading:11026647-Binding, Competitive,
pubmed-meshheading:11026647-COS Cells,
pubmed-meshheading:11026647-DNA, Complementary,
pubmed-meshheading:11026647-Humans,
pubmed-meshheading:11026647-Iodocyanopindolol,
pubmed-meshheading:11026647-Myocardium,
pubmed-meshheading:11026647-Radioligand Assay,
pubmed-meshheading:11026647-Receptors, Adrenergic, beta-1,
pubmed-meshheading:11026647-Receptors, Adrenergic, beta-2,
pubmed-meshheading:11026647-Receptors, Adrenergic, beta-3,
pubmed-meshheading:11026647-Transfection
|
pubmed:year |
2000
|
pubmed:articleTitle |
Binding properties of beta-blockers at recombinant beta1-, beta2-, and beta3-adrenoceptors.
|
pubmed:affiliation |
Klinik III für Innere Medizin der Universität zu Köln, Cologne, Germany. Petra.Schnabel@uni-koeln.de
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|